Our Quality Policy
At Oculogica, we innovate eye-tracking products for improved brain health. We apply the highest standards in our daily activities in order to satisfy the expectations and unmet needs of patients and healthcare professionals.
We maintain the effectiveness of our quality system through continuous monitoring and measurement of objectives related to regulatory compliance, customer requirements, product expertise and technical support.
Oculogica’s proprietary, patented technology transforms the way concussion is diagnosed.
Founded by a neurosurgeon and research scientist, Oculogica® has developed the first FDA authorized non-invasive, baseline free, technology to aid in diagnosis of concussion, also known as mild traumatic brain injury (mTBI). Oculogica is also conducting research with world-class medical institutions to bring personalized medicine to concussion diagnosis and treatment, and, ultimately, improve outcomes for the millions of people who annually suffer TBI and concussion.